Chatham Capital Group, Inc. United Therapeutics Corp Transaction History

Chatham Capital Group, Inc.

$543 Million
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$166.16 - $213.96 $1.66 Million - $2.14 Million	-9,994 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$184.32 - $216.08 $2,764 - $3,241	15 Added 0.15%	9,994 $2.16 Million
Q3 2021 Oct 13, 2021	SELL	$179.86 - $214.88 $35,612 - $42,546	-198 Reduced 1.95%	9,979 $1.85 Million
Q2 2021 Jul 28, 2021	BUY	$170.47 - $211.93 $170 - $211	1 Added 0.01%	10,177 $1.83 Million
Q1 2021 Apr 29, 2021	BUY	$153.94 - $174.85 $28,478 - $32,347	185 Added 1.85%	10,176 $1.7 Million

Q4 2020 Jan 27, 2021	SELL	$101.87 - $151.79 $6,112 - $9,107	-60 Reduced 0.6%	9,991 $1.52 Million
Q3 2020 Oct 22, 2020	SELL	$99.9 - $121.13 $3,996 - $4,845	-40 Reduced 0.4%	10,051 $1.02 Million
Q2 2020 Jul 20, 2020	BUY	$92.74 - $125.82 $4,266 - $5,787	46 Added 0.46%	10,091 $1.22 Million
Q1 2020 May 01, 2020	SELL	$79.39 - $115.35 $2,778 - $4,037	-35 Reduced 0.35%	10,045 $953,000
Q4 2019 Jan 31, 2020	SELL	$78.31 - $95.34 $6,656 - $8,103	-85 Reduced 0.84%	10,080 $888,000
Q3 2019 Nov 08, 2019	SELL	$74.85 - $85.99 $12,724 - $14,618	-170 Reduced 1.64%	10,165 $811,000
Q2 2019 Jul 24, 2019	BUY	$76.06 - $120.81 $5,400 - $8,577	71 Added 0.69%	10,335 $807,000
Q1 2019 May 09, 2019	BUY	$107.15 - $126.84 $7,929 - $9,386	74 Added 0.73%	10,264 $1.21 Million
Q4 2018 Feb 06, 2019	BUY	$101.4 - $128.73 $91,260 - $115,856	900 Added 9.69%	10,190 $1.11 Million
Q2 2018 Jul 30, 2018	BUY	$101.14 - $118.31 $20,228 - $23,662	200 Added 2.2%	9,290 $1.05 Million
Q1 2018 May 09, 2018	SELL	$107.21 - $151.94 $64,325 - $91,164	-600 Reduced 6.19%	9,090 $1.02 Million
Q4 2017 Feb 01, 2018	BUY	$118.58 - $151.28 $9,486 - $12,102	80 Added 0.83%	9,690 $1.43 Million
Q2 2017 Aug 09, 2017	BUY	N/A	9,610	9,610 $1.25 Million

Others Institutions Holding UTHR

# of Institutions

561

Shares Held

43.1M

Call Options Held

501K

Put Options Held

529K

Black Rock Inc. New York, NY

5.57M
Shares

$1.75 Billion
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

4.68M
Shares

$1.47 Billion
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.41M
Shares

$1.07 Billion
0.14% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$899 Million
7.91% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.15M
Shares

$677 Million
0.78% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chatham Capital Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chatham Capital Group, Inc. with notifications on news.

Account